Neumora Therapeutics Inc (NASDAQ:NMRA) currently has a daily average trading volume of 1.04M but it saw 3145911 shares traded in last market. With a market cap of 164.99M USD, the company’s current market price of $1.02 came rising about 13.12 while comparing to the previous closing price of $0.9. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.19 and as low as $0.61. In the recent trading on the day, stock has struck highest price mark of $0.9 while lowest mark touched by it was $1.18.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BofA Securities which downgraded the stock as “Underperform” in its note to investors issued on April 02, 2025, recommending a price target of $1 for it. Stifel also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $6 and $2.
Over the week, NMRA’s stock price is moving 28.09% up while it is 0.00% when we observe its performance for the past one month. Year-to-date it is -90.05% down and over the past year, the stock is showing a downside performance of -90.38%.
Currently, Neumora Therapeutics Inc’s total number of outstanding shares is 161.75M with 27.57% of that held by the insiders while 60.19% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -113.00% and return on equity (ROE) at -79.05%. Stock’s beta reads 2.58. Stock has a price to book (P/B) ratio of 0.72. Its return on asset (ROA) is -73.01% on average.
